ACCP: Recent Episodes
ACCP
The podcast of the American College of Clinical Pharmacy (ACCP). Offers interviews about a variety of clinical topics, interviews with influencers in clinical pharmacy, and overview of various research topics.
Postgraduate training can be overwhelming. Listen for some tips on how to maintain wellbeing as a postgraduate trainee.
Transparency on how programs are designed and residents are evaluated in the context of changes to the ASHP Standards and competency areas, goals, and objectives (CAGOs).
How does ACCP advocate for you and how can you advocate for your patients and profession? Learn from ACCP's Senior Director of Government Affairs, John K. McGlew.
Excellent advice as you transition out of a training program and into that first 'real job' from Lindsay Davis and Jessica Merlo.
Article referenced during the podcast: Guidelines for Pharmacists Integrating into Primary Care Teams https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819955/
Perspective from Dr. Garrett Schramm, Senior Director of Education at Mayo Clinic, on advancing within your clinical pharmacy career. Spoiler alert: Everyone's path is unique!
Current PGY2s provide helpful advice on making that quick transition from PGY1 to PGY2.
Dr. Nick Peters from the Pharmacy to Dose critical care podcast provides insight on increasing your podcasting presence.
Nervous about your first on-call experience? Afraid to match to a program that requires on-call service? Dr. Brooke Smith, current PGY2 in critical care, shares two years worth of on-call experience.
Is becoming a residency program director in your future? Learn what this career path entails and how to get started from current and past Mayo Clinic residency program directors, Dr. Abby Krauter and Dr. Scott Nei.
Dr. Mia Lussier provides insight and advice on how to successfully transition to a new practitioner role.
Dr. Henry Okoroike provides insight and advice on how to successfully transition to a new practitioner role.
Want to get started in peer review? Get an inside look at the peer review process from Dr. Erika Ernst, University of Iowa College of Pharmacy Associate Professor and Journal of the American College of Clinical Pharmacy Associate Editor - including advice on how to get started.
Where do you see yourself in 10 years? The ACCP Resident Advisory Committee assembled a panel representing four career paths and advice on how to get there. This podcast focuses on career advice for the early practitioner. Moderated by Henry Okoroike, guests include: Deborah Bondi, Elias Chahine, Christina Doligalski, and Alexander Flannery.
0:00 – 8:08 Can you share some advice that made a positive impact on you early on in your career?
8:08 – 16:12 What advice do you have for trainees about continuing to be a well-rounded clinical pharmacist?
16:12 – 18:33 What is your advice for new graduates and clinicians desiring to get involved in research and publishing?
18:33 – 22:50 What additional advice do you have on work/life balance?
Whether you are about to begin your postgraduate training or finishing it, you are certain to find some helpful advice. Watch the full video: https://www.accp.com/resandfel/advice.aspx.
Where do you see yourself in 10 years? The ACCP Resident Advisory Committee assembled a panel representing four career paths and advice on how to get there. This podcast focuses on how involvement in ACCP contributed to the panelists professional development. Moderated by Henry Okoroike, guests include: Deborah Bondi, Elias Chahine, Christina Doligalski, and Alexander Flannery.
0:00 – 5:58 Describe how you first became involved with ACCP.
5:58 – 10:10 How has your involvement in ACCP affected or directed your career path?
10:10 – 17:47 What was your path to becoming a fellow of ACCP (FCCP)?
17:47 – 24:05 What contribution to ACCP or clinical pharmacy are you the most proud of?
Whether you are about to begin your postgraduate training or finishing it, you are certain to find some helpful advice. Watch the full video: https://www.accp.com/resandfel/advice.aspx.
Co-founder and CEO of Your Financial Pharmacist, Tim Ulbrich, discusses financial wellness for postgraduate trainees. He offers advice on debt management, investing, and protecting your income now and throughout your career.
Dr. Jerry L. Bauman, JACCP Editor-in-Chief, discusses key factors for designing, completing, and publishing retrospective research, like chart reviews. Full text of the manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1064.
Dr. Daniel Longyhore discusses the importance of postgraduate trainees disseminating their research.
Hopefully you matched in Phase 1, but what do you need to know about Phase 2 just in case? Learn from a colleague who has been through it.
Dr. Autumn Walkerly provides an overview of Spravato (esketamine) nasal spray for treatment resistant depression.
References:
Gaynes BN, Lux L, Gartlehner G, et al. Defining treatment-resistant depression. Depress Anxiety. 2020;37(2):134-45.
Irwin MN, VandenBerg A. Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action. Ment Health Clin. 2021;11(3):200-10.
Rush AJ, Trivedi MH, Wisniewski SR, et al. "Acute and longer-term outcomes in depressed outpatient requiring one or several treatment steps: A STAR*D report". Am J Psychiatry. 2006. 163(11):1905-17.
Daly EJ, Trivedi MH, Janik A, et al. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry. 2019;76(9):893-903.
Fu DJ, Ionescu DF, Li X, et al. Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I). J Clin Psychiatry. 2020;81(3):19m13191.
Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-38.
Dr. Aaron Devanathan provides perspective on advancing your research career via the fellowship or Ph.D. route.
References:
Bauman JL, Evans WE. Pharm.D.-only Investigators Are Critical to the Profession: Let’s Preserve the Fellowship as an Equally Important Way to Prepare Future Clinical Pharmaceutical Scientists: Or the Case Against the “All-Ph.D.” Pharmacotherapy. 2009 February;29(2):129–133. https://doi.org/10.1592/phco.29.2.129.
O’Donnell JM, Anand S, Brown SD, et al. Report of the 2018-2019 Research and Graduate Affairs Committee. Am J of Pharm Ed. 2019;83(10):Article 7595.
Assemi M, Suchanek Hudmon K, Sowinski KM, Corelli RL. Educational Background and Academic Rank of Faculty Members within US Schools of Pharmacy. Am J of Pharm Ed. 2016;80(4):Article 61.
Morbitzer KA, McLaughlin JE, Devanathan AS, et al. How-to guide for overcoming barriers of research and scholarship training in Pharm.D. and pharmacy residency programs. J Am Coll Clin Pharm. 2021;1-11. https://doi.org/10.1002/jac5.1426.
ACCP Podcast for Residents by Residents: Dr. Monica Xi discusses careers in academia for residency trained pharmacists with Dr. Jeremy Daniel, Pharm.D., BCPS, BCPP, associate professor at South Dakota State University College of Pharmacy and Allied Health Professions.
Reference:
Young S, Vos SS, Cantrell M, Shaw R. Factors associated with students' perception of preceptor excellence. Am J Pharm Educ. 2014 Apr 17;78(3):53. doi: 10.5688/ajpe78353.
Episode 44: ACCP Podcast for Residents by Residents: PAD; management of pain, agitation, and delirium in COVID-19 patients
References:
- Adams CD, Altshuler J, Barlow BL, et al. Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID-19. Pharmacotherapy 2020;40(12):1180–1191. doi: 10.1002/phar.2471.
- Devlin JW, O’Neal Jr. HR, Thomas C, et al. Strategies to Optimize ICU Liberation (A to F) Bundle Performance in Critically Ill Adults With Coronavirus Disease 2019. Crit Care Expl 2020; 2:e0139. DOI: 10.1097/CCE.0000000000000139.
- Devlin JW, Skrobik Y, Gelinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med 2018;46(9):e825-73. DOI: 10.1097/CCM.0000000000003299.
- Alhazzani W, Evans L, Alshami F, et al. Surviving Sepsis Campaign Guidelines on the Management of Adults with Coronavirus Disease 2019 (COVID-19) in the ICU. Crit Care Med 2021;49(3):e219-34.
- National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Moss M, Huang DT, Brower RG, et al. "Early neuromuscular blockade in the acute respiratory distress syndrome". N Engl J Med. 2019. 380(21):1997-2008.
- Papazian L, Forel J, Gacouin A, et al. "Neuromuscular blockers in early acute respiratory distress syndrome". N Engl J Med. 2010. 363(12):1107-1116.
Episode 43: ACCP Podcast for Residents by Residents: Answers to so many questions about board certification
'hhawbq8c' Episode 42: ACCP Podcast for Residents by Residents: Use of Oral Antibiotic Agents for Gram Negative Bacteremias
Episode 41: ACCP Podcast for Residents by Residents: SGLT2 Inhibitors and Heart Failure
Episode 35: ACCP Podcast for Residents by Residents: Paving your way in Ambulatory Care
Episode 33: ACCP Podcast for Residents by Residents: How to stay current with the primary literature.
Deans Guglielmo and Sullivan discuss Pharmacists as Health Care Providers based on their experience in their respective states, California and Washington.
Drs. Kaakeh and Stringer provide an overview of Hyperinsulinemic-Euglycemic Therapy in CCB and BB Overdose.
Drs. DeVane and Dagenais explore the use of intranasal lidocaine for acute management of headaches.
Drs. Lodise and Pai discuss weight-based dosing of antibiotics in obese and underweight patients.
Perspective on innovations in medication safety from Dr.Sandra Kane Gill guest editor for the Pharmacotherapy themed issue..
Dr. Gale provides an overview of antihyperglycemic medications and their impact on cardiovascular outcomes.
More is not always better: Drs. Hanretty and Gallagher present data in support of short course antibiotic therapy.
The editors-in-chief of ACCPs two official journals discuss the journals histories, scopes, and future plans.
Drs. Patel and Carris update us on EPA-registered repellants for mosquitoes transmitting viral disease.
Dr. Alyssa Peckham discusses her team's research on predictors of gabapentin overuse with Pharmacotherapy EIC, Dr. Lindsay DeVane.
Dr. Haines explores the evolving role of non-statin therapy with Pharmacotherapy commentary authors Drs. Sisson and Dixon.
Dr. JoEllen Rodgers and Ms. Kristin Smith share significant insight into the secondary analyses of PARADIGM-HF
Dr. C. Lindsay DeVane, Editor-in-Chief of Pharmacotherapy, talks ketamine with Dr. Kyle Weant and Dr. Lauren Linder.
Drs. Jenkins and Nutescu explore the use of oral antithrombotic agents, focusing on dual and triple therapeutic approaches
Dr. DeVane talks with Dr. Taryn Bainum about her research on antidepressant discontinuation syndrome in critically ill hospitalized patients
Guest Editors Jeffrey Bishop and Vicki Ellingrod discuss Pharmacotherapy's themed issue on Precision Medicine
Drs. Tran and DeVane discuss the prevalence and treatment of opioid use disorder in pregnancy.
Dr. Douglas Jennings reviews inhaled pulmonary vasodilator therapy for management of right ventricular dysfunction s/p LVAD or CTX.
Dr. Candice Garwood provides insight into bridge therapy for patients using vitamin K antagonists for atrial fibrillation.
Dr. Michael J. Rybak discusses Enterococcus faecium infections and the use of new and old treatment regimens, including combination therapy.
Clinical Pharmacist Competencies: Drs. Saseen and Seaton discuss the new ACCP guideline which describes six essential competency domains for clinical pharmacists.
SGLT2 Inhibitors: Drs. Nuffer and Trujillo discuss the nonglycemic outcomes, clinical implications, and adverse effects associated with SGLT2 inhibitor therapy in patients with type 2 diabetes.
This episode features clinical queries posed by ACCP members. Our experts, James Coons from the University of Pittsburgh, Zach Stacey from St. Louis College of Pharmacy, and Jessica Tilton from the University of Illinois answer questions on a variety of different topics including various uses of amiodarone, ranolazine, sotalol, and ivabradine.
Antimicrobial dosing in pediatric obesity. Drs. Le and Natale discuss their review article "Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing" published in the March 2017 issue of Pharmacotherapy.
The pediatric obesity epidemic. Drs. Le and Natale discuss their review article "Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing" published in the March 2017 issue of Pharmacotherapy.
Dr. Susan Conway is the lead author of Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know in the February 2017 issue of Pharmacotherapy. In this podcast, she provides additional perspectives applicable to clinicians prescribing and monitoring anticoagulation.
Join Dr. Rachel Chennault, Director, ACCP Practice-Based Research Network (PBRN), as she discusses the advantages and opportunities with several members of the ACCP PBRN.
Sam Johnson, Director of Health Policy and Interprofessional Affairs for ACCP, interviews Lee Vermeulen and Glen Schumock, guest editors of Pharmacotherapy's themed issue on the rising costs of pharmaceuticals. Hear their perspectives on cost containment efforts, drug pricing and our current health care environment. Please note, that the opinions expressed on this podcast are of the individuals being interviewed not of ACCP.
ACCP discusses the ACCP Medicare Initiative, the results of the 2016 election, the potential repeal and replace of the ACA, and the opportunities that exist for ACCP as healthcare gets discussed again at the federal level.
ACCP interviews Kim Kelly, founding member of ACCP, about the early days of clinical pharmacy, the beginning of ACCP, and the challenges and success that both ACCP and clinical pharmacy have experienced over the last 37 years.
ACCP interviews Hala Durrah, patient care advocate and keynote speaker at the 2016 ACCP Annual Meeting.